Comprehensive Stability Study Protocol for Low-Dose Formulation
This protocol outlines the procedures for conducting stability studies on low-dose formulations, focusing on the drug’s potency, degradation, and dissolution profiles under varying environmental conditions.
| Parameter | Details |
|---|---|
| Product Name | [Low-Dose Formulation Name] |
| Batch Number | [Batch Number] |
| Objective | To evaluate the stability of low-dose formulations under specified environmental conditions. |
| Test Parameters |
– Assay – Degradation Products  – Appearance |
| Storage Conditions | [e.g., 25°C/60% RH, 40°C/75% RH] |
| Test Intervals | [Specify intervals: 0, 3, 6, 12 months, etc.] |
| Acceptance Criteria | No significant loss in potency or appearance degradation. |
| Regulatory Guidelines | ICH Q1A(R2), FDA, EMA |
| Signatories | QA, QC, Regulatory Affairs |